{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:06:14Z","timestamp":1784293574563,"version":"3.55.0"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s40272-026-00760-7","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:04:24Z","timestamp":1783944264000},"page":"387-403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety and Effectiveness of Pain Medications for Migraine Management During Pregnancy and Lactation"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1071-515X","authenticated-orcid":false,"given":"Liza","family":"Smirnoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas Garzon","family":"Mancera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayina","family":"Hyppolite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Cocores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"760_CR1","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211.","DOI":"10.1177\/0333102417738202"},{"issue":"6","key":"760_CR2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/bcpt.13579","volume":"128","author":"S Amundsen","year":"2021","unstructured":"Amundsen S, Nordeng H, Fuskevag OM, Nordmo E, Sager G, Spigset O. Transfer of triptans into human breast milk and estimation of infant drug exposure through breastfeeding. Basic Clin Pharmacol Toxicol. 2021;128(6):795\u2013804.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"760_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/head.14024","volume":"61","author":"R Burch","year":"2021","unstructured":"Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States: updated age, sex, and socioeconomic-specific estimates from government health surveys. Headache. 2021;61(1):60\u20138.","journal-title":"Headache"},{"issue":"9","key":"760_CR4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1046\/j.1526-4610.1999.3909625.x","volume":"39","author":"DA Marcus","year":"1999","unstructured":"Marcus DA, Scharff L, Turk D. Longitudinal prospective study of headache during pregnancy and postpartum. Headache. 1999;39(9):625\u201332.","journal-title":"Headache"},{"issue":"4","key":"760_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1468-1331.2006.01184.x","volume":"13","author":"LJ Stovner","year":"2006","unstructured":"Stovner LJ, Zwart JA, Hagen K, Terwindt GM, Pascual J. Epidemiology of headache in Europe. Eur J Neurol. 2006;13(4):333\u201345.","journal-title":"Eur J Neurol"},{"issue":"3","key":"760_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1046\/j.1468-2982.2003.00480.x","volume":"23","author":"G Sances","year":"2003","unstructured":"Sances G, Granella F, Nappi RE, Fignon A, Ghiotto N, Polatti F, et al. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia. 2003;23(3):197\u2013205.","journal-title":"Cephalalgia"},{"issue":"4 Suppl 1","key":"760_CR7","first-page":"S26","volume":"53","author":"M Aube","year":"1999","unstructured":"Aube M. Migraine in pregnancy. Neurology. 1999;53(4 Suppl 1):S26\u20138.","journal-title":"Neurology"},{"issue":"8","key":"760_CR8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1046\/j.1468-2982.2000.00112.x","volume":"20","author":"F Granella","year":"2000","unstructured":"Granella F, Sances G, Pucci E, Nappi RE, Ghiotto N, Napp G. Migraine with aura and reproductive life events: a case control study. Cephalalgia. 2000;20(8):701\u20137.","journal-title":"Cephalalgia"},{"issue":"10","key":"760_CR9","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1111\/head.15010","volume":"65","author":"S Wieland","year":"2025","unstructured":"Wieland S, Emborg MS, de Wolff MG, Damm P, Buchgreitz L, Chalmer MA, et al. Use of antimigraine medication before pregnancy and in the first trimester: a cross-sectional study. Headache. 2025;65(10):1704\u201315.","journal-title":"Headache"},{"issue":"4","key":"760_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1177\/1753495X18769170","volume":"11","author":"SK Afridi","year":"2018","unstructured":"Afridi SK. Current concepts in migraine and their relevance to pregnancy. Obstet Med. 2018;11(4):154\u20139.","journal-title":"Obstet Med."},{"issue":"22","key":"760_CR11","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.2169\/internalmedicine.51.8542","volume":"51","author":"E Hoshiyama","year":"2012","unstructured":"Hoshiyama E, Tatsumoto M, Iwanami H, Saisu A, Watanabe H, Inaba N, et al. Postpartum migraines: a long-term prospective study. Intern Med. 2012;51(22):3119\u201323.","journal-title":"Intern Med"},{"issue":"3","key":"760_CR12","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1468-2982.2008.01704.x","volume":"29","author":"F Facchinetti","year":"2009","unstructured":"Facchinetti F, Allais G, Nappi RE, D\u2019Amico R, Marozio L, Bertozzi L, et al. Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study. Cephalalgia. 2009;29(3):286\u201392.","journal-title":"Cephalalgia"},{"issue":"6","key":"760_CR13","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/head.13536","volume":"59","author":"N Skajaa","year":"2019","unstructured":"Skajaa N, Szepligeti SK, Xue F, Sorensen HT, Ehrenstein V, Eisele O, et al. Pregnancy, birth, neonatal, and postnatal neurological outcomes after pregnancy with migraine. Headache. 2019;59(6):869\u201379.","journal-title":"Headache"},{"issue":"10","key":"760_CR14","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1111\/j.1526-4610.2011.01961.x","volume":"51","author":"MA Williams","year":"2011","unstructured":"Williams MA, Peterlin BL, Gelaye B, Enquobahrie DA, Miller RS, Aurora SK. Trimester-specific blood pressure levels and hypertensive disorders among pregnant migraineurs. Headache. 2011;51(10):1468\u201382.","journal-title":"Headache"},{"key":"760_CR15","doi-asserted-by":"publisher","first-page":"b664","DOI":"10.1136\/bmj.b664","volume":"338","author":"CD Bushnell","year":"2009","unstructured":"Bushnell CD, Jamison M, James AH. Migraines during pregnancy linked to stroke and vascular diseases: US population based case-control study. BMJ. 2009;338:b664.","journal-title":"BMJ"},{"issue":"1","key":"760_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1212\/CON.0000000000001070","volume":"28","author":"M Rayhill","year":"2022","unstructured":"Rayhill M. Headache in pregnancy and lactation. Continuum (Minneap Minn). 2022;28(1):72\u201392.","journal-title":"Continuum (Minneap Minn)."},{"key":"760_CR17","doi-asserted-by":"crossref","unstructured":"Headaches in Pregnancy and Postpartum: ACOG Clinical Practice Guideline No. 3. Obstet Gynecol. 2022;139(5):944-72.","DOI":"10.1097\/AOG.0000000000004766"},{"issue":"12","key":"760_CR18","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41574-021-00553-7","volume":"17","author":"AZ Bauer","year":"2021","unstructured":"Bauer AZ, Swan SH, Kriebel D, Liew Z, Taylor HS, Bornehag CG, et al. Paracetamol use during pregnancy\u2014a call for precautionary action. Nat Rev Endocrinol. 2021;17(12):757\u201366.","journal-title":"Nat Rev Endocrinol"},{"key":"760_CR19","doi-asserted-by":"crossref","unstructured":"Saldanha IJ, Roth JL, Chen KK, Zullo AR, Adam GP, Konnyu KJ, et al. AHRQ Comparative Effectiveness Reviews. Management of primary headaches in pregnancy. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020.","DOI":"10.23970\/AHRQEPCCER234"},{"issue":"1","key":"760_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12940-025-01208-0","volume":"24","author":"D Prada","year":"2025","unstructured":"Prada D, Ritz B, Bauer AZ, Baccarelli AA. Evaluation of the evidence on acetaminophen use and neurodevelopmental disorders using the Navigation Guide methodology. Environ Health. 2025;24(1):56.","journal-title":"Environ Health"},{"issue":"14","key":"760_CR21","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1001\/jama.2024.3172","volume":"331","author":"VH Ahlqvist","year":"2024","unstructured":"Ahlqvist VH, Sj\u00f6qvist H, Dalman C, Karlsson H, Stephansson O, Johansson S, et al. Acetaminophen use during pregnancy and children\u2019s risk of autism, ADHD, and intellectual disability. JAMA. 2024;331(14):1205\u201314.","journal-title":"JAMA"},{"issue":"2","key":"760_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/jcv2.12020","volume":"1","author":"K Gustavson","year":"2021","unstructured":"Gustavson K, Ystrom E, Ask H, Ask Torvik F, Hornig M, Susser E, et al. Acetaminophen use during pregnancy and offspring attention deficit hyperactivity disorder\u2014a longitudinal sibling control study. JCPP Adv. 2021;1(2):e12020.","journal-title":"JCPP Adv."},{"key":"760_CR23","unstructured":"European Medicines Agency, Pharmacovigilance Risk Assessment Committee. PRAC recommendations on signals: adopted at the 12-15 March 2019 PRAC meeting [Internet]. Amsterdam: European Medicines Agency; 2019 Apr 8. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/prac-recommendation\/prac-recommendations-signals-adopted-12-15-march-2019-prac-meeting_en.pdf"},{"key":"760_CR24","unstructured":"American College of Obstetricians and Gynecologists. Prenatal acetaminophen use and outcomes in children. Am J Obstet Gynecol. 2017;216(3):B14-B15.25.Fleischman SJ. ACOG affirms safety and benefits of acetaminophen during pregnancy [Internet]. Washington (DC): American College of Obstetricians and Gynecologists; 2025 Sep. Available from: https:\/\/www.acog.org\/news\/news-releases\/2025\/09\/acog-affirms-safety-benefits-acetaminophen-pregnancy"},{"key":"760_CR25","unstructured":"Fleischman SJ. ACOG affirms safety and benefits of acetaminophen during pregnancy [Internet]. Washington (DC): American College of Obstetricians and Gynecologists; 2025 Sep. Available from: https:\/\/www.acog.org\/news\/news-releases\/2025\/09\/acog-affirms-safety-benefits-acetaminophen-pregnancy"},{"issue":"1","key":"760_CR26","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/head.13665","volume":"60","author":"R Burch","year":"2020","unstructured":"Burch R. Epidemiology and treatment of menstrual migraine and migraine during pregnancy and lactation: a narrative review. Headache. 2020;60(1):200\u201316.","journal-title":"Headache"},{"issue":"1","key":"760_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1300\/J115v26n01_05","volume":"26","author":"P Tomasulo","year":"2007","unstructured":"Tomasulo P. LactMed-new NLM database on drugs and lactation. Med Ref Serv Q. 2007;26(1):51\u20138.","journal-title":"Med Ref Serv Q"},{"issue":"2","key":"760_CR28","first-page":"135","volume":"1","author":"CM Berlin Jr","year":"1980","unstructured":"Berlin CM Jr, Yaffe SJ, Ragni M. Disposition of acetaminophen in milk, saliva, and plasma of lactating women. Pediatr Pharmacol (New York). 1980;1(2):135\u201341.","journal-title":"Pediatr Pharmacol (New York)"},{"issue":"23","key":"760_CR29","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1001\/jama.2021.7939","volume":"325","author":"JH VanderPluym","year":"2021","unstructured":"VanderPluym JH, Halker Singh RB, Urtecho M, Morrow AS, Nayfeh T, Torres Roldan VD, et al. Acute treatments for episodic migraine in adults: a systematic review and meta-analysis. JAMA. 2021;325(23):2357\u201369.","journal-title":"JAMA"},{"issue":"11","key":"760_CR30","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1016\/j.mayocp.2025.01.023","volume":"100","author":"Z Wang","year":"2025","unstructured":"Wang Z, VanderPluym JH, Halker Singh RB, Alsibai RA, Roellinger DL, Murad MH. Safety of triptans in treating migraines in pregnant women: a target trial emulation. Mayo Clin Proc. 2025;100(11):1956\u201362.","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"760_CR31","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s00228-016-2127-9","volume":"72","author":"S Amundsen","year":"2016","unstructured":"Amundsen S, Ovrebo TG, Amble NM, Poole AC, Nordeng H. Use of antimigraine medications and information needs during pregnancy and breastfeeding: a cross-sectional study among 401 Norwegian women. Eur J Clin Pharmacol. 2016;72(12):1525\u201335.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"760_CR32","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12884-017-1399-0","volume":"17","author":"GE Harris","year":"2017","unstructured":"Harris GE, Wood M, Eberhard-Gran M, Lundqvist C, Nordeng H. Patterns and predictors of analgesic use in pregnancy: a longitudinal drug utilization study with special focus on women with migraine. BMC Pregnancy Childbirth. 2017;17(1):224.","journal-title":"BMC Pregnancy Childbirth"},{"key":"760_CR33","doi-asserted-by":"publisher","first-page":"1481378","DOI":"10.3389\/fphar.2024.1481378","volume":"15","author":"A Berard","year":"2024","unstructured":"Berard A, Strom S, Albrecht D, Kori S. Anti-migraine medications safety during pregnancy in the US. Front Pharmacol. 2024;15:1481378.","journal-title":"Front Pharmacol"},{"issue":"7","key":"760_CR34","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1111\/head.12375","volume":"54","author":"SA Ephross","year":"2014","unstructured":"Ephross SA, Sinclair SM. Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registry. Headache. 2014;54(7):1158\u201372.","journal-title":"Headache"},{"issue":"4","key":"760_CR35","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1526-4610.2010.01619.x","volume":"50","author":"K Nezvalova-Henriksen","year":"2010","unstructured":"Nezvalova-Henriksen K, Spigset O, Nordeng H. Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian Mother and Child Cohort Study. Headache. 2010;50(4):563\u201375.","journal-title":"Headache"},{"issue":"1","key":"760_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97092-y","volume":"11","author":"A Berard","year":"2021","unstructured":"Berard A, Strom S, Zhao JP, Kori S, Albrecht D. Dihydroergotamine and triptan use to treat migraine during pregnancy and the risk of adverse pregnancy outcomes. Sci Rep. 2021;11(1):19302.","journal-title":"Sci Rep"},{"issue":"9","key":"760_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011971","volume":"6","author":"ME Wood","year":"2016","unstructured":"Wood ME, Frazier JA, Nordeng HM, Lapane KL. Longitudinal changes in neurodevelopmental outcomes between 18 and 36 months in children with prenatal triptan exposure: findings from the Norwegian Mother and Child Cohort Study. BMJ Open. 2016;6(9):e011971.","journal-title":"BMJ Open"},{"issue":"12","key":"760_CR38","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000213678","volume":"104","author":"M Camanni","year":"2025","unstructured":"Camanni M, van Gelder M, Cantarutti A, Nordeng H, Lupattelli A. Association of prenatal exposure to triptans, alone or combined with other migraine medications, and neurodevelopmental outcomes in offspring. Neurology. 2025;104(12):e213678.","journal-title":"Neurology"},{"issue":"6","key":"760_CR39","doi-asserted-by":"publisher","first-page":"e2215333","DOI":"10.1001\/jamanetworkopen.2022.15333","volume":"5","author":"GM Harris","year":"2022","unstructured":"Harris GM, Wood M, Ystrom E, Nordeng H. Association of maternal use of triptans during pregnancy with risk of attention-deficit\/hyperactivity disorder in offspring. JAMA Netw Open. 2022;5(6):e2215333.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"760_CR40","doi-asserted-by":"publisher","first-page":"333102424125266","DOI":"10.1177\/03331024241252666","volume":"44","author":"F Puledda","year":"2024","unstructured":"Puledda F, Sacco S, Diener HC, Ashina M, Al-Khazali HM, Ashina S, et al. International Headache Society global practice recommendations for the acute pharmacological treatment of migraine. Cephalalgia. 2024;44(8):3331024241252666.","journal-title":"Cephalalgia"},{"issue":"3","key":"760_CR41","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1365-2125.1996.tb00185.x","volume":"41","author":"RE Wojnar-Horton","year":"1996","unstructured":"Wojnar-Horton RE, Hackett LP, Yapp P, Dusci LJ, Paech M, Ilett KF. Distribution and excretion of sumatriptan in human milk. Br J Clin Pharmacol. 1996;41(3):217\u201321.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"760_CR42","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/head.13700","volume":"60","author":"SD Silberstein","year":"2020","unstructured":"Silberstein SD, Shrewsbury SB, Hoekman J. Dihydroergotamine (DHE)\u2014then and now: a narrative review. Headache. 2020;60(1):40\u201357.","journal-title":"Headache"},{"key":"760_CR43","unstructured":"National Institute of Child Health and Human Development. Dihydroergotamine. In: Drugs and Lactation Database (LactMed\u00ae) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006 [updated 2021 Feb 15]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501173\/"},{"key":"760_CR44","unstructured":"AbbVie Inc. UBRELVY (ubrogepant) tablets, for oral use [prescribing information]. North Chicago, IL: AbbVie Inc.; 2025. Available from: https:\/\/www.rxabbvie.com\/pdf\/ubrelvy_pi.pdf"},{"key":"760_CR45","unstructured":"Pfizer Inc. NURTEC ODT (rimegepant) orally disintegrating tablets, for oral use [prescribing information]. New York, NY: Pfizer Inc.; 2026. Available from: https:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=4314"},{"key":"760_CR46","unstructured":"Pfizer Inc. ZAVZPRET (zavegepant) nasal spray [prescribing information]. New York, NY: Pfizer Inc.; 2025. Available from: https:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=4591"},{"key":"760_CR47","unstructured":"National Library of Medicine. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US); 2000. Available from: https:\/\/clinicaltrials.gov\/"},{"issue":"3","key":"760_CR48","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1089\/bfm.2021.0250","volume":"17","author":"TE Baker","year":"2022","unstructured":"Baker TE, Croop R, Kamen L, Price P, Stock DA, Ivans A, et al. Human milk and plasma pharmacokinetics of single-dose rimegepant 75 mg in healthy lactating women. Breastfeed Med. 2022;17(3):277\u201382.","journal-title":"Breastfeed Med"},{"key":"760_CR49","volume-title":"Drugs and lactation database (LactMed\u00ae) [Internet]","author":"National Institute of Child Health and Human Development","year":"2006","unstructured":"National Institute of Child Health and Human Development. Rimegepant. In: Drugs and lactation database (LactMed\u00ae) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006."},{"key":"760_CR50","volume-title":"Drugs and lactation database (LactMed\u00ae) [Internet]","author":"National Institute of Child Health and Human Development","year":"2006","unstructured":"National Institute of Child Health and Human Development. Ubrogepant. In: Drugs and lactation database (LactMed\u00ae) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006."},{"key":"760_CR51","doi-asserted-by":"publisher","DOI":"10.1111\/head.70036","author":"A Jakate","year":"2026","unstructured":"Jakate A, Weng Y, Shkrodova A, Fisniku O, Ding D, Morton K, et al. A phase 1 study of the breast milk and plasma pharmacokinetics of zavegepant 10 mg intranasal dose in healthy lactating women. Headache. 2026. https:\/\/doi.org\/10.1111\/head.70036.","journal-title":"Headache"},{"issue":"3","key":"760_CR52","doi-asserted-by":"publisher","first-page":"228 e1","DOI":"10.1016\/j.ajog.2011.11.019","volume":"206","author":"RK Hernandez","year":"2012","unstructured":"Hernandez RK, Werler MM, Romitti P, Sun L, Anderka M, National Birth Defects Prevention S. Nonsteroidal antiinflammatory drug use among women and the risk of birth defects. Am J Obstet Gynecol. 2012;206(3):228 e1-238.","journal-title":"Am J Obstet Gynecol"},{"issue":"7411","key":"760_CR53","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7411.368","volume":"327","author":"DK Li","year":"2003","unstructured":"Li DK, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ. 2003;327(7411):368.","journal-title":"BMJ"},{"issue":"15","key":"760_CR54","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1503\/cmaj.110454","volume":"183","author":"HR Nakhai-Pour","year":"2011","unstructured":"Nakhai-Pour HR, Broy P, Sheehy O, Berard A. Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion. CMAJ. 2011;183(15):1713\u201320.","journal-title":"CMAJ"},{"issue":"7281","key":"760_CR55","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1136\/bmj.322.7281.266","volume":"322","author":"GL Nielsen","year":"2001","unstructured":"Nielsen GL, Sorensen HT, Larsen H, Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ. 2001;322(7281):266\u201370.","journal-title":"BMJ"},{"issue":"4","key":"760_CR56","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/bdrb.20085","volume":"77","author":"B Ofori","year":"2006","unstructured":"Ofori B, Oraichi D, Blais L, Rey E, Berard A. Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: a nested case-control study. Birth Defects Res B Dev Reprod Toxicol. 2006;77(4):268\u201379.","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"issue":"4","key":"760_CR57","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nrneurol.2015.29","volume":"11","author":"S Amundsen","year":"2015","unstructured":"Amundsen S, Nordeng H, Nezvalova-Henriksen K, Stovner LJ, Spigset O. Pharmacological treatment of migraine during pregnancy and breastfeeding. Nat Rev Neurol. 2015;11(4):209\u201319.","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"760_CR58","doi-asserted-by":"publisher","first-page":"E177","DOI":"10.1503\/cmaj.130605","volume":"186","author":"S Daniel","year":"2014","unstructured":"Daniel S, Koren G, Lunenfeld E, Bilenko N, Ratzon R, Levy A. Fetal exposure to nonsteroidal anti-inflammatory drugs and spontaneous abortions. CMAJ. 2014;186(5):E177\u201382.","journal-title":"CMAJ"},{"issue":"1","key":"760_CR59","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","volume":"132","author":"ACOG Committee Opinion No","year":"2018","unstructured":"ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy. Obstet Gynecol. 2018;132(1):e44\u201352.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"760_CR60","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/0002-9378(84)90195-9","volume":"149","author":"RJ Townsend","year":"1984","unstructured":"Townsend RJ, Benedetti TJ, Erickson SH, Cengiz C, Gillespie WR, Gschwend J, et al. Excretion of ibuprofen into breast milk. Am J Obstet Gynecol. 1984;149(2):184\u20136.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"760_CR61","first-page":"457","volume":"1","author":"RT Weibert","year":"1982","unstructured":"Weibert RT, Townsend RJ, Kaiser DG, Naylor AJ. Lack of ibuprofen secretion into human milk. Clin Pharm. 1982;1(5):457\u20138.","journal-title":"Clin Pharm"},{"issue":"5","key":"760_CR62","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/S0002-9378(11)90771-6","volume":"168","author":"S Ito","year":"1993","unstructured":"Ito S, Blajchman A, Stephenson M, Eliopoulos C, Koren G. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol. 1993;168(5):1393\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"760_CR63","volume-title":"Drugs and lactation database (LactMed\u00ae) [Internet]","author":"National Institute of Child Health and Human Development","year":"2006","unstructured":"National Institute of Child Health and Human Development. Aspirin. In: Drugs and lactation database (LactMed\u00ae) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006."},{"issue":"2","key":"760_CR64","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1177\/0890334417695207","volume":"33","author":"P Datta","year":"2017","unstructured":"Datta P, Rewers-Felkins K, Kallem RR, Baker T, Hale TW. Transfer of low dose aspirin into human milk. J Hum Lact. 2017;33(2):296\u20139.","journal-title":"J Hum Lact"},{"issue":"1","key":"760_CR65","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/head.70016","volume":"66","author":"J Robblee","year":"2025","unstructured":"Robblee J, Minen MT, Friedman BW, Cortel-LeBlanc MA, Cortel-LeBlanc A, Orr SL. 2025 guideline update to acute treatment of migraine for adults in the emergency department: the American Headache Society evidence assessment of parenteral pharmacotherapies. Headache. 2025;66(1):53\u201376.","journal-title":"Headache"},{"issue":"15","key":"760_CR66","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1001\/jama.2013.278343","volume":"310","author":"B Pasternak","year":"2013","unstructured":"Pasternak B, Svanstr\u00f6m H, M\u00f8lgaard-Nielsen D, Melbye M, Hviid A. Metoclopramide in pregnancy and risk of major congenital malformations and fetal death. JAMA. 2013;310(15):1601\u201311.","journal-title":"JAMA"},{"key":"760_CR67","unstructured":"U.S. Food and Drug Administration. Promethazine hydrochloride tablets [prescribing information] [Internet]. Silver Spring (MD): U.S. Food and Drug Administration. Available from: https:\/\/dailymed.nlm.nih.gov\/dailymed\/search.cfm?labeltype=all&query=promethazine+hydrochloride"},{"issue":"10S","key":"760_CR68","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14309\/ajg.0000000000001958","volume":"117","author":"K Dunbar","year":"2022","unstructured":"Dunbar K, Yadlapati R, Konda V. Heartburn, nausea, and vomiting during pregnancy. Am J Gastroenterol. 2022;117(10S):10\u20135.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"760_CR69","first-page":"49","volume":"9","author":"KG Palmer","year":"2004","unstructured":"Palmer KG, James LP. Methemoglobinemia associated with metoclopramide therapy in a neonate. J Pediatr Pharmacol Ther. 2004;9(1):49\u201354.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"760_CR70","volume-title":"Drugs and lactation database (LactMed\u00ae) [Internet]","author":"National Institute of Child Health and Human Development","year":"2006","unstructured":"National Institute of Child Health and Human Development. Promethazine. In: Drugs and lactation database (LactMed\u00ae) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006."},{"key":"760_CR71","volume-title":"Drugs and lactation database (LactMed\u00ae) [Internet]","author":"National Institute of Child Health and Human Development","year":"2006","unstructured":"National Institute of Child Health and Human Development. Prochlorperazine. In: Drugs and lactation database (LactMed\u00ae) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006."},{"key":"760_CR72","volume-title":"Drugs and lactation database (LactMed\u00ae) [Internet]","author":"National Institute of Child Health and Human Development","year":"2006","unstructured":"National Institute of Child Health and Human Development. Metoclopramide. In: Drugs and lactation database (LactMed\u00ae) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006."},{"key":"760_CR73","doi-asserted-by":"crossref","unstructured":"Loder E, Weizenbaum E, Frishberg B, Silberstein S. Choosing wisely in headache medicine: the American Headache Society's List of Five Things Physicians and Patients Should Question. Headache. 2013.","DOI":"10.1111\/head.12278"},{"key":"760_CR74","unstructured":"Management of Headache in Pregnant Women: US HealthConnect \/ Practical Neurology; 2024 [Available from: https:\/\/practicalneurology.com\/diseases-diagnoses\/headache-pain\/management-of-headache-in-pregnant-women\/31998\/."},{"issue":"1","key":"760_CR75","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/head.12203","volume":"54","author":"ML Browne","year":"2014","unstructured":"Browne ML, Van Zutphen AR, Botto LD, Louik C, Richardson S, Druschel CM. Maternal butalbital use and selected defects in the national birth defects prevention study. Headache. 2014;54(1):54\u201366.","journal-title":"Headache"},{"key":"760_CR76","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/j.1526-4610.2008.01217.x","volume":"48","author":"ME Bigal","year":"2008","unstructured":"Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population based study. Headache. 2008;48:1157\u201368.","journal-title":"Headache"},{"issue":"10","key":"760_CR77","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1046\/j.1526-4610.2001.01189.x","volume":"41","author":"SD Silberstein","year":"2001","unstructured":"Silberstein SD, McCrory DC. Butalbital in the treatment of headache: history, pharmacology, and efficacy. Headache. 2001;41(10):953\u201367.","journal-title":"Headache"},{"issue":"S10","key":"760_CR78","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.1002\/jcph.1113","volume":"58","author":"S Ito","year":"2018","unstructured":"Ito S. Opioids in breast milk: pharmacokinetic principles and clinical implications. J Clin Pharmacol. 2018;58(S10):S151\u201363.","journal-title":"J Clin Pharmacol"},{"key":"760_CR79","volume-title":"Drugs and lactation database (LactMed\u00ae)","author":"National Institute of Child Health and Human Development","year":"2006","unstructured":"National Institute of Child Health and Human Development. Butalbital. In: Drugs and lactation database (LactMed\u00ae). Bethesda (MD): National Library of Medicine (US); 2006."},{"issue":"10","key":"760_CR80","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1111\/head.15001","volume":"65","author":"L Smirnoff","year":"2025","unstructured":"Smirnoff L, Moskatel L, Shaw B, He Z, Peretz A. A retrospective cohort study to evaluate the effectiveness and safety profile of occipital nerve blocks in the treatment of migraine during pregnancy. Headache. 2025;65(10):1727\u201333.","journal-title":"Headache"},{"issue":"6","key":"760_CR81","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1097\/AOG.0000000000000555","volume":"124","author":"S Govindappagari","year":"2014","unstructured":"Govindappagari S, Grossman TB, Dayal AK, Grosberg BM, Vollbracht S, Robbins MS. Peripheral nerve blocks in the treatment of migraine in pregnancy. Obstet Gynecol. 2014;124(6):1169\u201374.","journal-title":"Obstet Gynecol"},{"key":"760_CR82","unstructured":"National Library of Medicine. Lidocaine hydrochloride injection [prescribing information] [Internet]. Bethesda (MD): National Library of Medicine (US); 2026. Available from: https:\/\/dailymed.nlm.nih.gov\/dailymed\/search.cfm?labeltype=all&query=lidocaine"},{"issue":"1","key":"760_CR83","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/head.13390","volume":"59","author":"D Mehta","year":"2019","unstructured":"Mehta D, Leary MC, Yacoub HA, El-Hunjul M, Kincaid H, Koss V, et al. The effect of regional anesthetic sphenopalatine ganglion block on self-reported pain in patients with status migrainosus. Headache. 2019;59(1):69\u201376.","journal-title":"Headache"},{"key":"760_CR84","volume-title":"Drugs and lactation database (LactMed\u00ae)","author":"National Institute of Child Health and Human Development","year":"2006","unstructured":"National Institute of Child Health and Human Development. Lidocaine. In: Drugs and lactation database (LactMed\u00ae). Bethesda (MD): National Library of Medicine (US); 2006."},{"issue":"4","key":"760_CR85","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s40264-017-0627-x","volume":"41","author":"JEH Bergman","year":"2018","unstructured":"Bergman JEH, Lutke LR, Gans ROB, Addor MC, Barisic I, Cavero-Carbonell C, et al. Beta-blocker use in pregnancy and risk of specific congenital anomalies: a European case-malformed control study. Drug Saf. 2018;41(4):415\u201327.","journal-title":"Drug Saf"},{"issue":"10","key":"760_CR86","doi-asserted-by":"publisher","first-page":"665","DOI":"10.7326\/M18-0338","volume":"169","author":"BT Bateman","year":"2018","unstructured":"Bateman BT, Heide-Jorgensen U, Einarsdottir K, Engeland A, Furu K, Gissler M, et al. Beta-blocker use in pregnancy and the risk for congenital malformations: an international cohort study. Ann Intern Med. 2018;169(10):665\u201373.","journal-title":"Ann Intern Med"},{"key":"760_CR87","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1542\/peds.2016-0731","volume":"138","author":"BT Bateman","year":"2016","unstructured":"Bateman BT, Patorno E, Desai RJ, Seely EW, Mogun H, Maeda A, et al. Late pregnancy beta blocker exposure and risks of neonatal hypoglycemia and bradycardia. Pediatrics. 2016;138:3.","journal-title":"Pediatrics"},{"issue":"2","key":"760_CR88","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/HJH.0000000000002256","volume":"38","author":"A Kayser","year":"2020","unstructured":"Kayser A, Beck E, Hoeltzenbein M, Zinke S, Meister R, Weber-Schoendorfer C, et al. Neonatal effects of intrauterine metoprolol\/bisoprolol exposure during the second and third trimester: a cohort study with two comparison groups. J Hypertens. 2020;38(2):354\u201361.","journal-title":"J Hypertens"},{"issue":"9","key":"760_CR89","doi-asserted-by":"publisher","first-page":"333102424126973","DOI":"10.1177\/03331024241269735","volume":"44","author":"F Puledda","year":"2024","unstructured":"Puledda F, Sacco S, Diener HC, Ashina M, Al-Khazali HM, Ashina S, et al. International headache society global practice recommendations for preventive pharmacological treatment of migraine. Cephalalgia. 2024;44(9):3331024241269735.","journal-title":"Cephalalgia"},{"key":"760_CR90","volume":"23","author":"MPT Silveira","year":"2020","unstructured":"Silveira MPT, Possignollo J, Miranda VIA, Silveira MFD, Pizzol T, Serrate S, et al. Breastfeeding and risk classification of medications used during hospitalization for delivery: 2015 Pelotas Birth Cohort. Rev Bras Epidemiol. 2020;23:e200026.","journal-title":"Rev Bras Epidemiol"},{"issue":"12","key":"760_CR91","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00228-024-03753-y","volume":"80","author":"R Freppel","year":"2024","unstructured":"Freppel R, Gaboriau L, Richardson M, Ould Y, Domanski O, Pin\u00e7on C, et al. Beta-blockers and breastfeeding: a real-life prospective study. Eur J Clin Pharmacol. 2024;80(12):1937\u201343.","journal-title":"Eur J Clin Pharmacol"},{"key":"760_CR92","unstructured":"National Institute of Child Health and Human Development. Propranolol. In: Drugs and Lactation Database (LactMed\u00ae) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006 [updated 2021 Feb 15]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501091\/"},{"issue":"8","key":"760_CR93","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3453","volume":"37","author":"J Fu","year":"2021","unstructured":"Fu J, Tomlinson G, Feig DS. Increased risk of major congenital malformations in early pregnancy use of angiotensin-converting-enzyme inhibitors and angiotensin-receptor-blockers: a meta-analysis. Diabetes Metab Res Rev. 2021;37(8):e3453.","journal-title":"Diabetes Metab Res Rev"},{"key":"760_CR94","unstructured":"National Institute of Child Health and Human Development. Candesartan. In: Drugs and Lactation Database (LactMed\u00ae) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006 [updated 2021 Feb 15]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501234\/"},{"issue":"1","key":"760_CR95","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/head.14041","volume":"61","author":"IJ Saldanha","year":"2021","unstructured":"Saldanha IJ, Cao W, Bhuma MR, Konnyu KJ, Adam GP, Mehta S, et al. Management of primary headaches during pregnancy, postpartum, and breastfeeding: a systematic review. Headache. 2021;61(1):11\u201343.","journal-title":"Headache"},{"issue":"7","key":"760_CR96","first-page":"746","volume":"58","author":"F Alabdulrazzaq","year":"2012","unstructured":"Alabdulrazzaq F, Koren G. Fetal safety of calcium channel blockers. Can Fam Physician. 2012;58(7):746\u20137.","journal-title":"Can Fam Physician"},{"key":"760_CR97","unstructured":"National Institute of Child Health and Human Development. Verapamil. In: Drugs and Lactation Database (LactMed\u00ae) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006 [updated 2021 Feb 15]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501089\/"},{"key":"760_CR98","unstructured":"National Institute of Child Health and Human Development. Amlodipine. In: Drugs and Lactation Database (LactMed\u00ae) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006 [updated 2021 Feb 15]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501228\/"},{"issue":"11","key":"760_CR99","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.2174\/1570159X19666210211150856","volume":"19","author":"YC Kaplan","year":"2021","unstructured":"Kaplan YC, Demir O. Use of phenytoin, phenobarbital carbamazepine, levetiracetam lamotrigine and valproate in pregnancy and breastfeeding: risk of major malformations, dose-dependency, monotherapy vs polytherapy, pharmacokinetics and clinical implications. Curr Neuropharmacol. 2021;19(11):1805\u201324.","journal-title":"Curr Neuropharmacol"},{"issue":"12","key":"760_CR100","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1056\/NEJMoa2309359","volume":"390","author":"S Hernandez-Diaz","year":"2024","unstructured":"Hernandez-Diaz S, Straub L, Bateman BT, Zhu Y, Mogun H, Wisner KL, et al. Risk of autism after prenatal topiramate, valproate, or lamotrigine exposure. N Engl J Med. 2024;390(12):1069\u201379.","journal-title":"N Engl J Med"},{"key":"760_CR101","doi-asserted-by":"crossref","unstructured":"American College of O, Gynecologists. Headaches in pregnancy and postpartum: ACOG Clinical Practice Guideline No. 3. Obstetrics and Gynecology. 2022;139(5):944-72.","DOI":"10.1097\/AOG.0000000000004766"},{"issue":"1","key":"760_CR102","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s10194-023-01594-1","volume":"24","author":"C Lampl","year":"2023","unstructured":"Lampl C, MaassenVanDenBrink A, Deligianni CI, Gil-Gouveia R, Jassal T, Sanchez-Del-Rio M, et al. The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis. J Headache Pain. 2023;24(1):56.","journal-title":"J Headache Pain"},{"key":"760_CR103","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010608","author":"M Linde","year":"2013","unstructured":"Linde M, Mulleners WM, Chronicle EP, McCrory DC. Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev. 2013. https:\/\/doi.org\/10.1002\/14651858.CD010608.","journal-title":"Cochrane Database Syst Rev"},{"key":"760_CR104","volume-title":"Drugs and lactation database (LactMed\u00ae) [Internet]","author":"National Institute of Child Health and Human Development","year":"2006","unstructured":"National Institute of Child Health and Human Development. Topiramate. In: Drugs and lactation database (LactMed\u00ae) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006."},{"key":"760_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111446","volume":"138","author":"I Kacirova","year":"2021","unstructured":"Kacirova I, Grundmann M, Brozmanova H, Koristkova B. Monitoring topiramate concentrations at delivery and during lactation. Biomed Pharmacother. 2021;138:111446.","journal-title":"Biomed Pharmacother"},{"key":"760_CR106","volume-title":"Drugs and lactation database (LactMed\u00ae) [Internet]","author":"National Institute of Child Health and Human Development","year":"2006","unstructured":"National Institute of Child Health and Human Development. Valproic acid. In: Drugs and lactation database (LactMed\u00ae) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006."},{"issue":"6","key":"760_CR107","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1684\/epd.2022.1492","volume":"24","author":"T Tomson","year":"2022","unstructured":"Tomson T, Battino D, Bromley R, Kochen S, Meador KJ, Pennell PB, et al. Breastfeeding while on treatment with antiseizure medications: a systematic review from the ILAE Women Task Force. Epileptic Disord. 2022;24(6):1020\u201332.","journal-title":"Epileptic Disord"},{"key":"760_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2022.107151","volume":"214","author":"M Hedayat","year":"2022","unstructured":"Hedayat M, Nazarbaghi S, Heidari M, Sharifi H. Venlafaxine can reduce the migraine attacks as well as amitriptyline: a noninferiority randomized trial. Clin Neurol Neurosurg. 2022;214:107151.","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"760_CR109","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/bcpt.12497","volume":"118","author":"D Lassen","year":"2016","unstructured":"Lassen D, Ennis ZN, Damkier P. First-trimester pregnancy exposure to venlafaxine or duloxetine and risk of major congenital malformations: a systematic review. Basic Clin Pharmacol Toxicol. 2016;118(1):32\u20136.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"760_CR110","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/AOG.0000000000000410","volume":"124","author":"MS McDonagh","year":"2014","unstructured":"McDonagh MS, Matthews A, Phillipi C, Romm J, Peterson K, Thakurta S, et al. Depression drug treatment outcomes in pregnancy and the postpartum period: a systematic review and meta-analysis. Obstet Gynecol. 2014;124(3):526\u201334.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"760_CR111","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1001\/archpedi.158.4.312","volume":"158","author":"B Kallen","year":"2004","unstructured":"Kallen B. Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med. 2004;158(4):312\u20136.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"11","key":"760_CR112","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1176\/ajp.136.11.1483","volume":"136","author":"SH Erickson","year":"1979","unstructured":"Erickson SH, Smith GH, Heidrich F. Tricyclics and breast feeding. Am J Psychiatry. 1979;136(11):1483\u20134.","journal-title":"Am J Psychiatry"},{"key":"760_CR113","volume-title":"Drugs and lactation database (LactMed\u00ae) [Internet]","author":"National Institute of Child Health and Human Development","year":"2006","unstructured":"National Institute of Child Health and Human Development. Venlafaxine. In: Drugs and lactation database (LactMed\u00ae) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006."},{"key":"760_CR114","volume-title":"Drugs and lactation database (LactMed\u00ae) [Internet]","author":"National Institute of Child Health and Human Development","year":"2006","unstructured":"National Institute of Child Health and Human Development. Duloxetine. In: Drugs and lactation database (LactMed\u00ae) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006."},{"issue":"4","key":"760_CR115","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/head.14692","volume":"64","author":"AC Charles","year":"2024","unstructured":"Charles AC, Digre KB, Goadsby PJ, Robbins MS, Hershey A, American Headache S. Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: an American Headache Society position statement update. Headache. 2024;64(4):333\u201341.","journal-title":"Headache"},{"key":"760_CR116","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/978-1-4939-1031-1_20","volume":"814","author":"C Yallampalli","year":"2014","unstructured":"Yallampalli C, Chauhan M, Endsley J, Sathishkumar K. Calcitonin gene related family peptides: importance in normal placental and fetal development. Adv Exp Med Biol. 2014;814:229\u201340.","journal-title":"Adv Exp Med Biol"},{"issue":"7","key":"760_CR117","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1177\/0333102420983292","volume":"41","author":"R Noseda","year":"2021","unstructured":"Noseda R, Bedussi F, Gobbi C, Zecca C, Ceschi A. Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: analysis of the WHO pharmacovigilance database. Cephalalgia. 2021;41(7):789\u201398.","journal-title":"Cephalalgia"},{"issue":"1","key":"760_CR118","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s10194-024-01715-4","volume":"25","author":"R Noseda","year":"2024","unstructured":"Noseda R, Bedussi F, Gobbi C, Ceschi A, Zecca C. Calcitonin gene-related peptide antagonists in pregnancy: a disproportionality analysis in VigiBase((R)). J Headache Pain. 2024;25(1):10.","journal-title":"J Headache Pain"},{"issue":"4","key":"760_CR119","doi-asserted-by":"publisher","first-page":"333102423115808","DOI":"10.1177\/03331024231158083","volume":"43","author":"R Noseda","year":"2023","unstructured":"Noseda R, Bedussi F, Gobbi C, Ceschi A, Zecca C. Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: updated analysis in VigiBase(R). Cephalalgia. 2023;43(4):3331024231158083.","journal-title":"Cephalalgia"},{"key":"760_CR120","unstructured":"National Institute of Child Health and Human Development. Atogepant. In: Drugs and Lactation Database (LactMed\u00ae) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006 [updated 2023 Sep 18]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK594933\/"},{"issue":"2","key":"760_CR121","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1212\/WNL.0000000000207375","volume":"101","author":"MF Brin","year":"2023","unstructured":"Brin MF, Kirby RS, Slavotinek A, Adams AM, Parker L, Ukah A, et al. Pregnancy outcomes in patients exposed to onabotulinumtoxina treatment: a cumulative 29-year safety update. Neurology. 2023;101(2):e103\u201313.","journal-title":"Neurology"},{"issue":"5","key":"760_CR122","doi-asserted-by":"publisher","DOI":"10.1177\/03331024251327387","volume":"45","author":"HT Wong","year":"2025","unstructured":"Wong HT, Khan R, Buture A, Khalil M, Ahmed F. OnabotulinumtoxinA treatment for chronic migraine in pregnancy: an updated report of real-world headache and pregnancy outcomes over 14 years in Hull. Cephalalgia. 2025;45(5):3331024251327387.","journal-title":"Cephalalgia"},{"issue":"4","key":"760_CR123","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3390\/toxins17040192","volume":"17","author":"A Russo","year":"2025","unstructured":"Russo A, Iannone LF, Orologio I, Rivi V, Boccalini A, Lo Castro F, et al. Safety of onabotulinumtoxin-A for chronic migraine during pregnancy and breastfeeding: a narrative review. Toxins. 2025;17(4):192.","journal-title":"Toxins"},{"key":"760_CR124","unstructured":"U.S. Food and Drug Administration. BOTOX (onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use [prescribing information] [Internet]. Silver Spring (MD): U.S. Food and Drug Administration; 1989 [updated 2017]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/103000s5302lbl.pdf"},{"key":"760_CR125","unstructured":"Douthirt C. An Outbreak of Botulism in Tucumcari, New Mexico. Southwest Medicine. 1938:51-3."},{"issue":"6","key":"760_CR126","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1056\/NEJM197802092980620","volume":"298","author":"J Middaugh","year":"1978","unstructured":"Middaugh J. Botulism and breast milk. N Engl J Med. 1978;298(6):343.","journal-title":"N Engl J Med"},{"key":"760_CR127","volume-title":"StatPearls","author":"B Kuns","year":"2025","unstructured":"Kuns B, Rosani A, Patel P, Varghese D. Memantine. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025."},{"key":"760_CR128","doi-asserted-by":"publisher","first-page":"1496621","DOI":"10.3389\/fphar.2024.1496621","volume":"15","author":"G Li","year":"2024","unstructured":"Li G, Qu B, Zheng T, Duan S, Liu L, Liu Z. Role of memantine in adult migraine: a systematic review and network meta-analysis to compare memantine with existing migraine preventive medications. Front Pharmacol. 2024;15:1496621.","journal-title":"Front Pharmacol"},{"key":"760_CR129","unstructured":"Food and Drug Administration. Memantine: patient information and instructions for use. 2013."},{"issue":"1","key":"760_CR130","doi-asserted-by":"publisher","DOI":"10.1186\/2193-1801-2-573","volume":"2","author":"H Okuma","year":"2013","unstructured":"Okuma H, Iijima K, Yasuda T, Tokuoka K, Kitagawa Y. Preventive effect of cyproheptadine hydrochloride in refractory patients with frequent migraine. Springerplus. 2013;2(1):573.","journal-title":"Springerplus"},{"issue":"3","key":"760_CR131","first-page":"223","volume":"48","author":"BS Rao","year":"2000","unstructured":"Rao BS, Das DG, Taraknath VR, Sarma Y. A double blind controlled study of propranolol and cyproheptadine in migraine prophylaxis. Neurol India. 2000;48(3):223\u20136.","journal-title":"Neurol India"},{"key":"760_CR132","unstructured":"National Library of Medicine. Cyproheptadine hydrochloride [prescribing information] [Internet]. Bethesda (MD): National Library of Medicine (US); 2022. Available from: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=2b438746-14c2-44ef-a127-62b8d2efdc55"},{"issue":"2","key":"760_CR133","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s40264-016-0479-9","volume":"40","author":"F Etwel","year":"2017","unstructured":"Etwel F, Faught LH, Rieder MJ, Koren G. The risk of adverse pregnancy outcome after first trimester exposure to h1 antihistamines: a systematic review and meta-analysis. Drug Saf. 2017;40(2):121\u201332.","journal-title":"Drug Saf"},{"key":"760_CR134","unstructured":"National Institute of Child Health and Human Development. Cyproheptadine. In: Drugs and Lactation Database (LactMed\u00ae) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006 [updated 2021 Feb 15]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501263\/"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-026-00760-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-026-00760-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-026-00760-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:02:06Z","timestamp":1784293326000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-026-00760-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":134,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["760"],"URL":"https:\/\/doi.org\/10.1007\/s40272-026-00760-7","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"13 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Liza Smirnoff declares no conflicts of interest. Nicolas Garzon Mancera declares no conflicts of interest. Tayina Hyppolite declares no conflicts of interest. Daniela Lozano declares no conflicts of interest. Alexandra Cocores declares no conflicts of interest.","order":1,"name":"Ethics","label":"Conflicts of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":4,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Availability of Data and Material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LS, NGM, TN, DL and AC were involved in the conceptualization, methodology and writing of the original draft and review and editing of this manuscript. LS was involved in the supervision of this manuscript.","order":7,"name":"Ethics","label":"Authors Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}